These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 979659)
41. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
42. [Blood insulin, glucagon and glucose levels in latent diabetes mellitus determined during glucose tolerance test (effect of phenformin)]. Tikhonova NE Ter Arkh; 1982; 54(10):12-6. PubMed ID: 6758166 [No Abstract] [Full Text] [Related]
43. Hyperkalemia and hyperglycemic increments in plasma potassium in diabetes mellitus. Popp D; Achtenberg JF; Cryer PE Arch Intern Med; 1980 Dec; 140(12):1617-21. PubMed ID: 7006540 [TBL] [Abstract][Full Text] [Related]
44. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment. Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649 [TBL] [Abstract][Full Text] [Related]
45. [Ratio of somatostatin-glucagon secretion in diabetes mellitus]. Kostiuk EP Fiziol Zh (1978); 1985; 31(2):195-201. PubMed ID: 2860024 [No Abstract] [Full Text] [Related]
46. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects. Ross SA; Dupre J Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238 [TBL] [Abstract][Full Text] [Related]
47. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845 [TBL] [Abstract][Full Text] [Related]
48. The effect of dietary fiber on glucose and hormone responses to a mixed meal in normal subjects and in diabetic subjects with and without autonomic neuropathy. Levitt NS; Vinik AI; Sive AA; Child PT; Jackson WP Diabetes Care; 1980; 3(4):515-9. PubMed ID: 6257457 [TBL] [Abstract][Full Text] [Related]
49. Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma. Leichter SB; Pagliara AS; Grieder MH; Pohl S; Rosai J; Kipnis DM Am J Med; 1975 Feb; 58(2):285-93. PubMed ID: 46704 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application. Borghi VC; Wajchenberg BL; Albuquerque RH Clin Chim Acta; 1984 Jan; 136(1):39-48. PubMed ID: 6692564 [TBL] [Abstract][Full Text] [Related]
51. Plasma insulin and glucose profiles in normal, obese, and diabetic persons. Genuth SM Ann Intern Med; 1973 Dec; 79(6):812-22. PubMed ID: 4761908 [No Abstract] [Full Text] [Related]
52. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus. Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078 [TBL] [Abstract][Full Text] [Related]
53. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus. Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036 [TBL] [Abstract][Full Text] [Related]
54. Response of gut glucagon-like immunoreactivity to hypoglycemia in dogs. Ohneda A; Sasaki I; Naito H; Toda M; Ohneda M; Koizumi F Am J Physiol; 1989 Mar; 256(3 Pt 1):E431-8. PubMed ID: 2646947 [TBL] [Abstract][Full Text] [Related]
55. [Glucagon and insulin levels in diabetes mellitus patients]. Kosilova ES; Lobanova AM; Starosel'tseva LK; Perelygina AA Probl Endokrinol (Mosk); 1982; 28(1):3-6. PubMed ID: 7038662 [TBL] [Abstract][Full Text] [Related]
56. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity. Castells S; Avruskin T; Reddy CM; Hashemi SE Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938 [TBL] [Abstract][Full Text] [Related]
57. Somatostatin does not alter insulin-mediated glucose disposal. Meneilly GS; Elahi D; Minaker KL; Rowe JW J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337 [TBL] [Abstract][Full Text] [Related]
58. Insulin and glucagon response to glucose and arginine in two patients with "autoimmune" diabetes mellitus. Del Prete GF; Tiengo A; Bersani G; Nosadini R; Garotti C; Trisotto A Horm Metab Res; 1976 Mar; 8(2):149-50. PubMed ID: 1261966 [No Abstract] [Full Text] [Related]